Description

3-Quinolinecarboxylic Acid, 7-(4-Acetyl-1-Piperazinyl)-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in the synthesis of novel antibacterial agents, particularly within the fluoroquinolone class. It is primarily sought by pharmaceutical manufacturers and R&D organizations focused on developing next-generation antibiotics and therapeutic compounds.

Application

• Key Intermediate for Antibacterial Agents: Serves as a crucial building block in the synthesis of advanced fluoroquinolone antibiotics.
• Pharmaceutical R&D: Used in medicinal chemistry for the discovery and development of new therapeutic molecules targeting bacterial infections.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the production pathway for complex, high-value APIs.
• Chemical Reference Standard: Employed as a high-purity standard for analytical method development, validation, and quality control in pharmaceutical labs.
• Process Chemistry & Scale-Up: Utilized in optimizing synthetic routes and scaling production from laboratory to pilot and commercial scales.

Basic Information

Product Name	3-Quinolinecarboxylic Acid, 7-(4-Acetyl-1-Piperazinyl)-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-
CAS No.	93594-20-8
Molecular Formula	C19H20FN3O4
Molecular Weight	373.38 g/mol
Synonyms	7-(4-Acetylpiperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-acetyl-1-piperazinyl)-3-quinolinecarboxylic Acid; 7-(4-Acetyl-1-piperazinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Intermediate for Garenoxacin; Garenoxacin intermediate; T-3811 intermediate; OPC-17116 intermediate; BMS-284756 intermediate
EINECS	Contact for details

Quality Control

Every batch of this pharmaceutical intermediate is produced under strict quality management systems and undergoes comprehensive analytical testing. We ensure compliance with ICH guidelines and relevant pharmacopeial standards for impurities and identification. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming identity, purity, and impurity profile.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.